These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 203231)
21. [Cytostatic therapy of psoriasis]. Groth O Lakartidningen; 1979 Oct; 76(43):3770-1. PubMed ID: 583353 [No Abstract] [Full Text] [Related]
22. Therapy of psoriasis 1975. Van Scott EJ JAMA; 1976 Jan; 235(2):197-8. PubMed ID: 946030 [No Abstract] [Full Text] [Related]
23. An appraisal of current systemic chemotherapy for psoriasis. Farber EM; Pearlman D; Abel EA Arch Dermatol; 1976 Nov; 112 Spec no():1679-88. PubMed ID: 793537 [No Abstract] [Full Text] [Related]
24. Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey. van Wagenen G; DeConti RC; Handschumacher RE; Wade ME Am J Obstet Gynecol; 1970 Sep; 108(2):272-81. PubMed ID: 4952580 [No Abstract] [Full Text] [Related]
25. Nucleoside analogs in the treatment of nonneoplastic diseases. Calabresi P; Doolittle CH; Heppner GH; McDonald CJ Ann N Y Acad Sci; 1975 Aug; 255():190-201. PubMed ID: 1059354 [No Abstract] [Full Text] [Related]
26. Cutaneous uses of the antiproliferative drugs. McDonald CJ Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):934-9. PubMed ID: 4138632 [No Abstract] [Full Text] [Related]
27. New indications for 6-azauridine treatment in man. A review. Elis J; Rasková H Eur J Clin Pharmacol; 1972 Mar; 4(2):77-81. PubMed ID: 4570456 [No Abstract] [Full Text] [Related]
28. Psoriasis: a review. II. Baker H Dermatologica; 1975; 150(3):136-53. PubMed ID: 1098945 [TBL] [Abstract][Full Text] [Related]
29. THE EFFECT OF TRIACETYL AZAURIDINE ON PSORIASIS. TURNER RW; CALABRESI P J Invest Dermatol; 1964 Dec; 43():551-7. PubMed ID: 14234861 [No Abstract] [Full Text] [Related]
30. High-resolution chromatography provides the answer to the 15-year-old problem of azaribine toxicity. Kovach JS J Lab Clin Med; 1977 Nov; 90(5):771-2. PubMed ID: 578520 [No Abstract] [Full Text] [Related]
31. [Immunosuppressive agents in the treatment of psoriasis]. Ruszczak Z Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862 [No Abstract] [Full Text] [Related]
38. Automated analytical systems for drug development studies. V. A system for enzyme kinetic studies. Zhou J; Shearer EC; Hong J; Riley CM; Schowen RL J Pharm Biomed Anal; 1996 Sep; 14(12):1691-8. PubMed ID: 8887716 [TBL] [Abstract][Full Text] [Related]
39. Time-response curves in the evaluation of the clinical efficacy of drugs. Jankú I; Elis J; Rasková H Eur J Clin Pharmacol; 1971 Sep; 3(4):194-7. PubMed ID: 5151302 [No Abstract] [Full Text] [Related]
40. Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine. Slavik M; Smith KJ; Blanc O Biochem Pharmacol; 1982 Dec; 31(24):4089-92. PubMed ID: 6186258 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]